5412692026-01-012026-03-315412692026-03-315412692025-03-315412692025-04-012026-03-315412692026-01-012026-03-31in-capmkt:OtherExpenses1Member5412692026-01-012026-03-31in-capmkt:OtherExpenses2Member5412692025-04-012026-03-31in-capmkt:OtherExpenses1Member5412692025-04-012026-03-31in-capmkt:OtherExpenses2Member5412692026-03-31OtherNoncurrentFinancialAssetsDomain15412692026-03-31OtherNoncurrentAssetsDomain15412692026-03-31OtherCurrentFinancialAssetsDomain15412692026-03-31OtherCurrentAssetsDomain15412692026-03-31OtherNoncurrentFinancialLiabilitiesDomain15412692026-03-31OtherNoncurrentLiabilitiesDomain15412692026-03-31OtherCurrentFinancialLiabilitiesDomain15412692026-03-31OtherCurrentLiabilitiesDomain15412692026-01-012026-03-31in-capmkt:ReportableSegments1Member5412692026-01-012026-03-31in-capmkt:ReportableSegments2Member5412692025-04-012026-03-31in-capmkt:ReportableSegments1Member5412692025-04-012026-03-31in-capmkt:ReportableSegments2Member5412692026-01-012026-03-31in-capmkt:ReportableSegments1Member5412692026-01-012026-03-31in-capmkt:ReportableSegments2Member5412692025-04-012026-03-31in-capmkt:ReportableSegments1Member5412692025-04-012026-03-31in-capmkt:ReportableSegments2Member5412692026-01-012026-03-31in-capmkt:ReportableSegments1Member5412692026-03-31in-capmkt:ReportableSegments1Member5412692026-01-012026-03-31in-capmkt:ReportableSegments2Member5412692026-03-31in-capmkt:ReportableSegments2Member5412692026-01-012026-03-31in-capmkt:ReportableSegments1Member5412692026-03-31in-capmkt:ReportableSegments1Member5412692026-01-012026-03-31in-capmkt:ReportableSegments2Member5412692026-03-31in-capmkt:ReportableSegments2Member5412692026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15412692026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25412692025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15412692025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25412692026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares541269CHEMFABNOTLISTEDINE783X01023CHEMFAB ALKALIS LIMITEDMain BoardEquity2025-04-012026-03-312026-05-132026-05-07INRLakhsQuarterlyFourth quarterMulti segment2026-05-1314:30:002026-05-1318:00:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated74775700028008000775765000199783000268400001432000632320002142400079505000371299000763515000122500000122500003562000384200074040000484600000004846000281800076640004846000076640000143737000100.340.34000.340.34NOTES: <BR> <BR> 1 The Statement of Consolidated financial results comprises of the financial results of Chemfab Alkalis Limited (CAL) (“the Parent Company”), Chemfab Karaiikal Limited (CKKL) and Chemfab Hiitech Piping Limited (CHPL) ("the Subsidiaries") (together referred to as “the Group”). These financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Parent Company at their meeting held on 13 May 2026. <BR> 2 "During the current quarter ended 30 June 2025, the Parent Company had allotted Nil Equity shares of Rs. 10 each upon exercise of Employee stock options by the eligible employees under Employee's Stock Option Scheme ""CAESOS 2020"". <BR> " <BR> 2 The Group has identified its reportable segments in accordance with Ind AS 108 - Operating Segments. Accordingly, two reportable segments i.e. Chemicals and Related Products and PVC - O Pipes have been identified, the details of which are given below: <BR> (Amount Rs. In Lakhs) <BR> Sl. No. Particulars 3 Months ended 31/03/2026 " Preceding <BR> 3 Months ended 31/12/2025 " " Corresponding <BR> 3 months ended 31/03/2025 in the previous year " Current Year ended 31/03/2026 Previous year ended 31/03/2025 <BR> (Refer Note 7) (Unaudited) (Refer Note 7) (Audited) (Audited) <BR> I Segment Revenue <BR> a) Chemicals and related Products 6,168.19 5,380.87 6,078.96 21,814.51 20,292.38 <BR> b) PVC-O Pipes 1,311.24 1,464.95 3,153.46 9,346.75 13,145.05 <BR> 7,479.43 6,845.82 9,232.42 31,161.26 33,437.43 <BR> Less: Inter Segment Revenue (1.86) (31.37) - (58.99) - <BR> Net Segment Revenue 7,477.57 6,814.45 9,232.42 31,102.27 33,437.43 <BR> II Segment Result before tax <BR> a) Chemicals and related Products 143.74 (619.23) (43.99) (1,709.99) (2,310.07) <BR> b) PVC-O Pipes (87.08) 66.62 316.87 1,589.88 3,049.01 <BR> Total 56.66 (552.61) 272.88 (120.11) 738.94 <BR> Less: Inter Segment Result - - - - - <BR> Less: Finance Cost (214.24) (203.48) (156.56) (768.69) (492.50) <BR> Add: Other Income 280.08 276.76 137.62 868.80 711.79 <BR> Total Profit Before Tax 122.50 (479.33) 253.94 (20.00) 958.23 <BR> III Segment Assets: <BR> a) Chemicals and related Products 31,989.11 33,019.12 31,617.08 31,989.11 31,617.08 <BR> b) PVC-O Pipes 21,906.91 21,120.32 15,858.21 21,906.91 15,858.21 <BR> Total Segment Assets 53,896.02 54,139.44 47,475.29 53,896.02 47,475.29 <BR> Add: Unallocable assets 3,777.37 2,776.25 4,706.96 3,777.37 4,706.96 <BR> Total Assets 57,673.39 56,915.69 52,182.25 57,673.39 52,182.25 <BR> IV Segment Liabilities: <BR> a) Chemicals and related Products 5,453.32 6,232.34 3,546.82 5,453.32 3,546.82 <BR> b) PVC-O Pipes 2,194.70 1,208.69 2,181.34 2,194.70 2,181.34 <BR> Total Segment Liabilities 7,648.02 7,441.03 5,728.16 7,648.02 5,728.16 <BR> Add: Unallocable liabilities 12,484.68 12,003.47 8,455.28 12,484.68 8,455.28 <BR> Total Liabilities 20,132.70 19,444.50 14,183.44 20,132.70 14,183.44 <BR> <BR> <BR> 3 During the current year ended 31 March 2026, the Parent Company had allotted 10,000 Equity shares of Rs. 10 each upon exercise of Employee stock options by the eligible employees under Employee's Stock Option Scheme "CAESOS 2020". <BR> 4 "The Group has estimated and recognized the impact of implementation of the New Labour Codes under Employee benefits expense for the year ended 31 March 2026. The impact of the same is not material to the results for the year. <BR> <BR> The Group continues to monitor the issuance and finalisation of State Rules and further clarifications from the Government in respect of other aspects of the Labour Codes. Any additional impact arising from such developments will be assessed and appropriately accounted for in the Consolidated Financial Results as and when such rules are notified or clarifications are issued." <BR> 5 The Statement of Consolidated Assets and Liabilities as at 31 March 2026 and the Statement of Consolidated Cash Flows are provided as annexures to this Statement. <BR> 6 The Board of Directors of the Parent Company has recommended a final dividend of 12.50 % (Rs. 1.25 per Equity Share of Rs. 10 each) which is subject to the approval of the shareholders in the forthcoming Annual General Meeting of the Parent Company. <BR> 7 The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures of the full financial year ended 31 March 2026 and published year to date figure upto third quarter ended 31 December 2025 and audited figures of the full financial year ended 31 March 2025 and published year to date figures upto third quarter ended 31 December 2024 respectively. <BR> <BR> For Chemfab Alkalis Limited <BR> <BR> <BR> <BR> Suresh Krishnamurthi Rao <BR> Place: Chennai Chairman <BR> Date: 13 May 2026 DIN No: 001278092025-04-012026-03-31AuditedConsolidated311022700086880000319710700095018900026840000526820002632170007686900028419500015451150003199107000-20000000-20000001941200012853000322650000-342650000000-342650005908000-28357000-34265000059080000143737000103610332000-2.38-2.3800-2.38-2.38Direct Manufacturing Expenses - Power, Fuel & Others291032000Other Expenses80267000Direct Manufacturing Expenses - Power, Fuel & Others1123055000Other Expenses422060000386382300030554800000587600000079100000219090002270000021448400083000000449543100025903800013478000024076500084600083580000302500038777400025800000090481200036709600005767339000143737000361033200037540690003754069000814300000000302490008445490003067000000462500087984400041530000062830003064390003127220001560200008840420002204350001663700012312000011334260000020132700005767339000Other non-current financial assets21909000Other non-current assets83000000Other current financial assets3025000Other current assets258000000Other non-current financial liabilities30249000Other non-current liabilities4625000Other current financial liabilities156020000Other current liabilities220435000Chemicals and Related products616819000PVC-O Pipes131124000Chemicals and Related products2181451000PVC-O Pipes934675000747943000311612600018600058990007477570003110227000Chemicals and Related products14374000PVC-O Pipes-8708000Chemicals and Related products-170999000PVC-O Pipes1589880005666000-120110002142400076869000-28008000-8688000012250000-2000000Chemicals and Related products3198911000PVC-O Pipes219069100053896020003777370005767339000Chemicals and Related products545332000PVC-O Pipes219470000764802000124846800020132700007686900012800000-329070000038570000008878000000028419500000000109700080003700000-24840000-289690000-987100003929890003909890000001005200003809370000000000015245600091219100000000000000000000800023170000-48620000-8060300000097800000000365000000-39250000447800017992000749430000-2138000305677000-1194160000-11941600019486600075450000- Remeasurement of net defined benefit liability4264000- Fair value gain on investments in equity instruments designated as at FVTOCI-2040004060000- Remeasurement of net defined benefit liability8621000- Fair value gain on investments in equity instruments designated as at FVTOCI-20200084190001242000251100028180005908000AuditedtrueDeloitte Haskins and Sells LLPtrue2027-07-31